Results with Rituxan
In Rituxan® (rituximab) clinical trials, many people experienced symptom improvement as early as 2 weeks after their second infusion. And many saw that same improvement last through 6 months. That could mean 6 months of less swelling in your knees, or 6 months of less joint pain in your hands.
Tim—
clinical trial participant
living with RA since 1989
taking Rituxan since 2004
In a Rituxan clinical trial, people taking Rituxan for 1 year were shown to have significantly slowed the progression of damage to their joints. It's important to note that these people had tried other treatments, including anti-TNFs, which either stopped working or did not work well at all. But after taking Rituxan, many of them were finally able to experience the improvement they’d been looking for.
Next Subsequent Courses of Treatment
Indication
Rituxan® (rituximab) in combination with methotrexate is indicated to reduce signs and symptoms and to slow the progression of structural damage in adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate response to one or more TNF antagonist therapies.
Important Side Effect Information
Among the risks associated with Rituxan® (rituximab) are some potentially serious and life-threatening side effects, including:
- Serious infections, including progressive multifocal leukoencephalopathy (PML)
- Severe infusion reactions
- Tumor lysis syndrome (TLS)
- Severe skin reactions
Other potential serious side effects include Hepatitis B virus reactivation and heart problems.
Common Side Effects include infusion reactions and infections.
For more information please talk to you doctor and see the Rituxan Medication Guide.
This information does not take the place of talking to your doctor about your medical condition or your treatment. Talk with your doctor if you have any questions about your treatment with Rituxan.
